CO [Chinard Bloodrp] SC 13D: JOINT FILINGREEMENT [R CHINA HEALTHCARE INVESTMENT LIMITED Richard

[JOINT FILINGREEMENT [R CHINA HEALTHCARE INVESTMENT LIMITED Richard J. Kreider, Attorney-in-fact for William J. Janetschek, DirectorR CHINA GROWTH FUND L.P.Rsociates China Growth L.P., its General PartnerR China Growth Limited, its General Partner Richard J. Kreider, Attorney-in-fact for William J. Janetschek, DirectorRSOCIATES CHINA GROWTH L.P.] [Execution VersionNVERTIBLE NOTE PURCHASEREEMENT among CHINARD BLOODRPORATION andR CHINA HEALTHCARE INVESTMENT LIMITEDted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 2 SECTION2LE AND PURCHASE OF THE NOTES] [REGISTRATION RIGHTSREEMENT between CHINARD BLOODRPORATION andR CHINA HEALTHCARE INVESTMENT LIMITEDted April 27, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page Section1 DEFINITIONS 1 Section2 GENERAL; SECURITIES SUBJECT TO THISREEMENT] [Executionpy DIRECTOR INDEMNIFICATIONREEMENT between CHINARD BLOODRPORATION and JULIAN J. WOLHARDTted April 27, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTSntents Page 1. Interpretation 1 2. Indemnity 3 3.] [Executionpy INDEMNIFICATION PRIORITY AND INFORMATION SHARINGREEMENTreement InvestorRmpany This INDEMNIFICATION PRIORITY AND INFORMATION SHARINGREEMENT,ted of April 27, 2012 (this WHEREAS, thempany has entered into anvertible Note Purchasereementted of April 12mpany IndemnificationreementR Indemnified Parties , 2012 (the] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and GOLDEN MEDITECH STEM CELL (BVI)MPANY LIMITED, and GOLDEN MEDITECHS LIMITEDted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and TING ZHENGted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED andBERT CHENted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and YUE DENGted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and XIN XUted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [POWER OF ATTORNEY EX-99.11 a12-9554_1ex99d11.htm 12 EX-99.11] [POWER OF ATTORNEY EX-99.12 a12-9554_1ex99d12.htm 13 EX-99.12] [POWER OF ATTORNEY EX-99.13 a12-9554_1ex99d13.htm 14 EX-99.13]

By | 2016-02-04T17:22:54+00:00 May 1st, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

HPJ [Highpower International] 10-K/A:

[] [Independent Registered Public Accounting Firm’s Consent We consent to the incorporation by reference in the Registration Statement of Highpower International, Inc. and subsidiaries (the “Company”) on Form S-8 (File No.333-157443) and the Registration Statement on Form S-3 (File No. 333-168473) of our report dated March 30, 2012, with respect to our audit of the consolidated financial statements of the Company] [I, Dang Yu Pan, certify that: 1. I have reviewed this annual report on Form 10-K/A of Highpower International, Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [I, Henry Sun, certify that: 1. I have reviewed this annual report on Form 10-K/A of Highpower International, Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were]

OIIM [O2MICRO INTERNATIONAL] 20-F: 2 TABLE OFNTENTS PART I Item 1. Identity

[2 TABLE OFNTENTS PART I Item 1. Identity of Directors, Senior Management andvisors [5] Item 2. Offer Statistics and Expected Timetable [5] Item 3. Key Information [5] Item 4. Information on thempany [14] Item 4A. Unresolved Staffmments [22] Item 5. Operating and Financial Review and Prospects [22]] [2 Significant Subsidiaries of O 2 2 2 2 2 2 2 2 Internationalsetmpany, ayman Islandsmpany exh_81.htm 2 EX-8.1] [CERTIFICATION I, Sterling Du, certify that: 1. 2 I have reviewed this annual report on Form 20-F of O 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Perry Kuo, certify that: 1. O 2 Micro I have reviewed this annual report on Form 20-F of 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [2 O CERTIFICATION 2 (1) (2) the informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Sterling Du Chief Executive Officer Perry Kuo Chief Financial Officer and Principal Accounting Officer exh_13.htm] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 Wensent to theorporation by reference in Registration Statement Nos. 333-12670, 333-12672, 333-98425, 333-101452, 333-107975, 333-116596, 333-132251, 333-153436, and 333-162489 on Form S-8 of our reportsted April 25, 2012 relating to thensolidated financial statements of O Deloitte & Touche Taipei, Taiwan]

By | 2016-02-06T03:18:24+00:00 May 1st, 2012|Categories: Chinese Stocks, OIIM, Webplus ver|Tags: , , , , , |0 Comments

CLNT [Cleantech Solutions International,] PRE 14A: SCHEDULE 14A INFORMATION x o Check the appropriate

[SCHEDULE 14A INFORMATION x o Check the appropriate box: x Preliminary Proxy Statement o o Definitive Proxy Statement o Definitive Additional Materials o Cleantech Solutions International, Inc. N.A. Payment of Filing Fee (Check the appropriate box): x No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities]

MR [Mindray Medical International] 20-F: þ U.S. GAAP International Financial Reporting Standards as

[þ U.S. GAAP International Financial Reporting Standards as issued ¨ by the International Accounting Standards Board ¨ Other ¨ ¨ ¨ þ Page INTRODUCTION 1 PART I 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 27 ITEM 4A.] [LIST OF SUBSIDIARIES • Mindray (UK) Limited, incorporated in the United Kingdom • Mindray Research and Development Limited, incorporated in the British Virgin Islands • Mindray Global Limited, incorporated in the British Virgin Islands • Shenzhen Mindray Bio-Medical Electronics Co., Ltd., incorporated in the People’s Republic of China • Beijing Shen Mindray Medical Electronics Technology Research Institute Co., Ltd., incorporated] [CERTIFICATION I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Xu Hang Chairman and Co-Chief Executive Officer Li Xiting Director, President and Co-Chief Executive Officer Alex Lung Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 30, 2012 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

CO [China Cord Blood] 6-K: Execution Version CONVERTIBLE NOTE PURCHASE among CHINA CORD

[Execution Version CONVERTIBLE NOTE PURCHASE among CHINA CORD BLOOD CORPORATION and KKR CHINA HEALTHCARE INVESTMENT LIMITED Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page Section 1 2 Section 2 9 Section 3 9 Section 4 14 Section 5] [SENIOR CONVERTIBLE NOTE SECURITIES ACT CHINA CORD BLOOD CORPORATION 7% SENIOR CONVERTIBLE NOTE Original Principal Amount: US$65,000,000 Holder Principal and Issuance Date and Note Notes Other Notes Registration Rights Agreement FOR VALUE RECEIVED, China Cord Blood Corporation, an exempted company with limited liability incorporated in the Cayman Islands (the “Company”), hereby promises to pay to the order of KKR China] [EXECUTION COPY REGISTRATION RIGHTS AGREEMENT between CHINA CORD BLOOD CORPORATION and KKR CHINA HEALTHCARE INVESTMENT LIMITED April 27 Dated Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THIS AGREEMENT 5 Section 3] [DIRECTOR INDEMNIFICATION AGREEMENT between CHINA CORD BLOOD CORPORATION and JULIAN J. WOLHARDT Dated April 27, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Contents Page 1. Interpretation 1 2. Indemnity 3 3. Limitations on indemnity 3 4. Company’s liability 4 5. 4] [Execution Copy INDEMNIFICATION PRIORITY AND INFORMATION SHARING AGREEMENT Agreement KKR CHINA HEALTHCARE INVESTMENT LIMITED Investor KKR Company This INDEMNIFICATION PRIORITY AND INFORMATION SHARING AGREEMENT, dated as of April 27, 2012 (this “ Company Indemnification Agreement KKR Indemnified Parties WHEREAS, the Company has entered into a Convertible Note Purchase Agreement dated as of April 12, 2012 (the “ KKR Director WHEREAS,] [China Cord Blood Corporation Announces Completion of $65 Million Convertible Debt Financing with KKR HONG KONG, China, April 27, 2012 China Cord Blood Corporation (NYSE: CO) (“CCBC” or “the Company”), the first and largest cord blood banking operator in China, today announced that it has successfully closed a US$65 million convertible debt financing with funds affiliated with KKR China Growth]

By | 2016-02-29T14:50:16+00:00 April 30th, 2012|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: AMENDMENT AGREEMENT TO NON-QUALIFIED STOCK OPTION AGREEMENTS OF

[AMENDMENT AGREEMENT TO NON-QUALIFIED STOCK OPTION AGREEMENTS OF CHINA PHARMA HOLDINGS, INC WHEREAS, the Employment Agreement by and between the Company and the Optionee will cease its effect as of April 28, 2012; WHEREAS, the Nominating and Compensation Committee believes it is for the best interest of the Company to terminate the Subject Options on April 28, 2012 and the]

By | 2016-03-03T17:48:50+00:00 April 30th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 20-F: U.S.GAAP International Financial Reporting Standards issued STYLE=”font-family:Times New

[U.S.GAAP International Financial Reporting Standards issued STYLE="font-family:Times New Roman" SIZE="2">by the International Accounting Standards Board Other Page INTRODUCTION 1 PARTI 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THEMPANY] [LIST OF SUBSIDIARIES STYLE="font-family:Times New Roman" SIZE="2"> Mindray (UK) Limited,orporated in the United Kingdom Mindray Research and Development Limited,orporated in the British Virgin Islands Mindray Global Limited,orporated in the British Virgin Islands Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Beijing Shen Mindray Medical Electronics Technology Research Instituteorporated in the Peoples Republic of] [CERTIFICATION STYLE="font-family:Times New Roman" SIZE="2">I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [CERTIFICATION STYLE="font-family:Times New Roman" SIZE="2">I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [CERTIFICATION STYLE="font-family:Times New Roman" SIZE="2">I,ex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION Xu Hang Chairman and-Chief Executive Officer Li Xiting Director,PresidentandCo-ChiefExecutiveOfficerex Lung Chief Financial Officer d293110dex131.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2"> We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No. 333-178896) of Mindray Medical International Limited of our reportted April30, 2012 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form 20-F. Wesonsent]

MY [CHINA MING YANG WIND POWER] 20-F: 1 Conventions 1 PART I 2 Item 1.

[1 Conventions 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisors 2 Item 2. Offer Statistics And Expected Timetable 2 Item 3. Key Information 2 Item 4. Information of the Company 32 Item 4A. Unresolved Staff Comments 63 Item 5. Operating and Financial Review and Prospects 63 Item 6. Directors, Senior Management and Employees 84 Item] [Guangdong Mingyang Wind Power Group CO., LTD. Wind Turbine Supply Contract Contract No.: MY20111230 Buyer (Party A): Guangdong Mingyang Wind Power Group CO., LTD. Supplier (Party B): Inner Mongolia Mingyang Wind Power Equipment CO., LTD. 1. Product name, specification and model, quantity, unit price and amount: Product Name Specification Unit Quantity Unit Price Total Amount Wind turbine MY1.5 Set 33] [Inner Mongolia Mingyang Wind Power Equipment Co., Ltd Application for Loan To: Guangdong Mingyang Wind Power Industry Group Co., Ltd: The construction of the facility of Inner Mongolia Mingyang Wind Power Equipment Co., Ltd is under way as scheduled. The land of the plant has been granted. However, Inner Mongolia Mingyang Wind Power Equipment Co., Ltd has run short of] [Subrogation Agreement Transferor (hereinafter referred to as Part A): Zhongshan Mingyang Electrical Appliance Co., LTD. Location: Daling Administration Zone, Torch Development Park, Zhongshan, Guangdong Transferee (hereinafter referred to as Party B): Guangdong Mingyang Wind Power Industry Group Co., LTD. Location: Mingyang Industrial Park, Jianye Road, Torch Development Zone, Zhongshan, Guangdong Province WHEREAS, Party B being actual executor of the Inner] [Subrogation Agreement Transferor (hereinafter referred to as Part A): Zhongshan Mingyang Electrical Appliance Co., LTD. Location: Daling Administration Zone, Torch Development Park, Zhongshan, Guangdong Transferee (hereinafter referred to as Party B): Guangdong Mingyang Wind Power Industry Group Co., LTD. Location: Mingyang Industrial Park, Jianye Road, Torch Development Zone, Zhongshan, Guangdong Province WHEREAS, Party B being actual executor of the Inner] [• First Base Investment Limited (incorporated in Hong Kong) • KeyCorp Limited (incorporated in Hong Kong) • Sky Trillion Limited (incorporated in the British Virgin Islands) • King Venture Limited (incorporated in Hong Kong) • Tech Sino Limited (incorporated in Hong Kong) • Asiatech Holdings Limited (incorporated in Hong Kong) • Rich Wind Energy Two Corp. (incorporated in the British] [Certification by the Chief Executive Officer I, Chuanwei Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of China Ming Yang Wind Power Group Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Certification by the Chief Financial Officer I, Manfred Loong, certify that: 1. I have reviewed this annual report on Form 20-F of China Ming Yang Wind Power Group Limited; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Certification by the Chief Executive Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Chuanwei Zhang Chief Executive Officer] [Certification by the Chief Financial Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Manfred Loong Chief Financial Officer]

By | 2016-03-01T00:05:17+00:00 April 30th, 2012|Categories: Chinese Stocks, MY, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar